C H Unnikrishnan &Amp; Rajesh Abraham In Mumbai

Vodka for Russians, Feni for Indians?

The group is planning to make a foray in this hitherto unorganised sector by establishing a greenfield still (distilleries dedicated to cashew and coconut Feni) in Goa and to promote the product all across the country.

Elder Pharma eyes European firm

Elder Pharmaceuticals, one of the fast growing pharmaceutical formulation company, is getting ready to make its maiden overseas acquisition.

Loans to brokers: Banks to call back Rs 9,000 cr

Restriction on lending for shares to hit forthcoming IPOs.

Reliance Life catches US firm's eye

Stem cell research major GlobalStem in talks for a strategic alliance.

Lock-in blues for DLF investors

Confusion prevails on the lock-in period of the about-to-be allotted shares of DLF Universal to the minority shareholders.

Alkem, US firm plan JV for wound care product

The Rs 900-crore (Rs 9 billion) Alkem Laboratories and the leading US pharmaceutical and research company Oculus Innovative Sciences Inc are planning to set up a 50:50 joint venture in India

Leela to venture out into Mauritius, Abu Dhabi

Why the stock market rally will continue

Leela eyes stake in Actis Biologics

Moody's okays 3-year lock-in of ICRA stake

FIIs barred from buying retail IPOs

Sula eyes private equity funding

Merck to conduct cancer vaccine trials in India

US firm in talks with Actis for cell technology

Lupin for Europe foray via tie-ups

Clearstone eyes 2 more companies

Peregrine plans cancer drug trial in India

Morgan Stanley plans expansion

Dubai centre woos Indian fund houses

Matrix move to give 10% more to Mylan